Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients.
J Exp Med. 2021 Mar 1;218(3):e20201707. doi: 10.1084/jem.20201707.
J Exp Med. 2021.
PMID: 33231615
Free PMC article.